Medicinal Products Containing Searlimab, Enfortumab Vertebine, Gemtuzumab Ozogamicin, Glofitamab, Nivolumab and Relatlimab, Panitumumab, Ramucurumab

KuwaitTender notice for Medicinal Products Containing Searlimab, Enfortumab Vertebine, Gemtuzumab Ozogamicin, Glofitamab, Nivolumab and Relatlimab, Panitumumab, Ramucurumab. The reference ID of the tender is 117652808 and it is closing on 13 May 2025.

100% Secure Payments

Tender Details

  • Country: Czech Republic
  • Summary: Medicinal Products Containing Searlimab, Enfortumab Vertebine, Gemtuzumab Ozogamicin, Glofitamab, Nivolumab and Relatlimab, Panitumumab, Ramucurumab
  • KWT Ref No: 117652808
  • Deadline: 13 May 2025
  • Competition: ICB
  • Financier: Self Financed
  • Purchaser Ownership: Public
  • Tender Value: 3900000
  • Notice Type: Tender
  • Document Ref. No.: 238888-2025
  • Purchaser's Detail :
  • Purchaser : UNIVERSITY HOSPITAL HRADEC KRALOVE
    Address: Sokolska 581

    Town: Hradec Kralove - Novy Hradec Kralove

    Nuts -Code: CZ052

    Postal Code: 50005

    Phone: +420 495834015
    Email :jana.mala2@fnhk.cz

  • Description :
  • The subject of the public contract is continuous supplies of medicinal products containing caught, enfortumab management, gemtuzumab ozogamicin, glofitamab, nivolumab and relatlimab, panitumumab, ramucirumab for 4 years according to the current needs of the client.
    Part 1
    The subject of the Public Procurement is ongoingDelivery of medicinal products containing Panitumumab for 4 years according to the current needs of the contracting authority.
    Part 2
    The subject of the public contract is continuous supplies of medicinal products containing gemtuzumab ozogamicin for 4 years according to the current needs of the contracting authority.
    Part 3
    The subject of the public contract is ongoingSupplies of medicinal products containing Enfortumab Course for 4 years according to the current needs of the contracting authority.
    Part 4
    The subject of the public contract is the continuous supply of medicinal products containing glofitamab for 4 years according to the current needs of the contracting authority.
    Part 5
    The subject of the Public Procurement is ongoingDelivery of medicinal products containing caught for 4 years according to the current needs of the contracting authority.
    Part 6
    The subject of the Public Procurement is continuous supplies of medicinal products containing Nivolumab and Relatlimab for 4 years according to the current needs of the contracting authority.Delivery of Ramucirumab medicinal products for 4 years according to the current needs of the client.supplies
  • Documents :
  •  Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
KuwaitTender Features

KuwaitTender Features

Fresh and verified Tenders from Kuwait. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Invalid Captcha !

Get FREE SAMPLE TENDERS from Kuwait in your email inbox.

  Chat with us